| 1. | | Recruiting | Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Conditions: chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia |
| 2. | | No longer recruiting | Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer |
| 3. | | No longer recruiting | Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life |
| 4. | | Recruiting | Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
Conditions: adult anaplastic astrocytoma; adult anaplastic ependymoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; ... |
| 5. | | Recruiting | Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer |
| 6. | | No longer recruiting | Docetaxel in Treating Patients With Stage IV Prostate Cancer
Conditions: Pain; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life |
| 7. | | Recruiting | Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia |
| 8. | | Recruiting | Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Conditions: chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia |
| 9. | | Recruiting | Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
Conditions: primary central nervous system lymphoma; intraocular lymphoma |
| 10. | | Recruiting | Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma
Conditions: intraocular lymphoma; primary central nervous system lymphoma |
| 11. | | Recruiting | Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis
Condition: Cerebrotendinous Xanthomatosis |
| 12. | | Recruiting | Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome |
| 13. | | Completed | Purification of Testis-Stimulating Factor in Precocious Puberty
Condition: Precocious Puberty |
| 14. | | No longer recruiting | Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
Conditions: Osteoporosis; stage I breast cancer; stage IIIB breast cancer; menopausal symptoms; stage IIIA breast cancer; stage II breast cancer; Quality of Life |
| 15. | | Recruiting | Rituximab, Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Sodium Thiosulfate and Cytarabine in Treating Patients With Refractory or Recurrent Primary CNS Lymphoma
Conditions: Drug Toxicity; Thrombocytopenia; intraocular lymphoma; primary central nervous system lymphoma |
| 16. | | Terminated | Study of Dietary N-3 Fatty Acids in Patients with Retinitis Pigmentosa and Usher Syndrome
Conditions: Usher Syndrome; Retinitis Pigmentosa |
| 17. | | Recruiting | Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
Condition: Cushing's Syndrome |
